Acquired resistance and clonal evolution in melanoma during BRAF inhibitor therapy

BRAF inhibitors elicit rapid anti-tumor responses in the majority of patients with (V600)BRAF mutant melanoma, but acquired drug resistance is almost universal. We sought to identify the core resistance pathways and the extent of tumor heterogeneity during disease progression. We show that MAPK reac...

Πλήρης περιγραφή

Αποθηκεύτηκε σε:
Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς: Shi, Hubing, Hugo, Willy, Kong, Xiangju, Hong, Aayoung, Koya, Richard C., Moriceau, Gatien, Chodon, Thinle, Guo, Rongqing, Johnson, Douglas B., Dahlman, Kimberly B., Kelley, Mark C., Kefford, Richard F., Chmielowski, Bartosz, Glaspy, John A., Sosman, Jeffrey A., van Baren, Nicolas, Long, Georgina V., Ribas, Antoni, Lo, Roger S.
Μορφή: Artigo
Γλώσσα:Inglês
Έκδοση: 2013
Θέματα:
Article
Διαθέσιμο Online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3936420/
https://ncbi.nlm.nih.gov/pubmed/24265155
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/2159-8290.CD-13-0642
Ετικέτες: Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!

Παρόμοια τεκμήρια